VIDEO: Calabrese discusses FDA effort to withdraw avacopan approval, long COVID in ARDs

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage regarding the FDA’s effort to revoke its approval of avacopan for ANCA-associated vasculitis.The FDA has alleged that employees of the drug’s original manufacturer, ChemoCentryx, manipulated data in the ADVOCATE trial, which was the sole study the FDA